| 2023 | IL-6 Receptor Expression on the Surface of T Cells and Serum Soluble IL-6 Receptor Levels in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Soluble triggering receptor expressed on myeloid cell-1 reflects the cross-sectional activity of microscopic polyangiitis and granulomatosis with polyangiitis
| HELIYON |
| 2023 | Hepatic steatosis index at diagnosis has the potential for forecasting end-stage kidney disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| Journal of Rheumatic Diseases |
| 2023 | Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| YONSEI MEDICAL JOURNAL |
| 2023 | A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis
| ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY |
| 2023 | Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea
| SCIENTIFIC REPORTS |
| 2023 | Association between computed tomography-assessed sarcopenia and mortality in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES |
| 2023 | Clinical Link between the BARD Score at Diagnosis and Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Non-alcoholic fatty liver disease fibrosis score is a useful index for predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| FRONTIERS IN MEDICINE |
| 2023 | Acute Brain Infarction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Korean Single-Center Study | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY |
| 2023 | A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
| 2023 | Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Predictive potential of albumin-alkaline phosphatase ratio for cerebrovascular accident in patients with antineutrophil cytoplasmic antibody-associated vasculitis | ANNALS OF CLINICAL BIOCHEMISTRY |
| 2023 | New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| FRONTIERS IN MEDICINE |
| 2023 | Soluble Tyro-3 and Axl may reflect the current activity and renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Serum soluble interleukin-7 receptor alpha levels are negatively correlated with the simultaneous activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2023 | Acute coronary syndrome in antineutrophil cytoplasmic antibody-associated vasculitis: a Korean single-centre cohort study
| Journal of Rheumatic Diseases |
| 2023 | Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines
| Journal of Rheumatic Diseases |
| 2023 | Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria | RHEUMATOLOGY |
| 2023 | The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RHEUMATOLOGY |
| 2023 | Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center
| Journal of Rheumatic Diseases |
| 2023 | Cancer-associated vasculitides: a single-centre case series | CLINICAL RHEUMATOLOGY |
| 2023 | Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
| YONSEI MEDICAL JOURNAL |
| 2022 | Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| SCIENTIFIC REPORTS |
| 2022 | Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review
| JOURNAL OF CLINICAL MEDICINE |
| 2022 | Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis
| SCIENTIFIC REPORTS |
| 2022 | Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| IN VIVO |
| 2022 | BVAS version 3 and BVAS/GPA: standing on the same line? | CLINICAL RHEUMATOLOGY |
| 2022 | Association between mid-upper arm circumference and functional status in patients with advanced cancer | Clinical Nutrition Open Science |
| 2022 | Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis
| ANNALS OF PALLIATIVE MEDICINE |
| 2022 | Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis | ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2022 | Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients
| BMC NEPHROLOGY |
| 2022 | Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RENAL NUTRITION |
| 2022 | Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Journal of Rheumatic Diseases |
| 2022 | Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2
| JOURNAL OF CLINICAL MEDICINE |
| 2022 | Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2022 | Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002-2018 South Korea National Health Insurance Database
| FRONTIERS IN MEDICINE |
| 2022 | Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study
| PLOS ONE |
| 2022 | Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2022 | Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| DIAGNOSTICS |
| 2022 | Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2022 | Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2022 | New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
| 2022 | Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study
| JOURNAL OF IMMUNOLOGY RESEARCH |
| 2022 | Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea
| STROKE AND VASCULAR NEUROLOGY |
| 2022 | Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2022 | Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? | RHEUMATOLOGY |
http://orcid.org/0000-0002-8038-3341
(36072602700)
